Brexit is the wrong prescription, says European pharma industry

LONDON, Feb 24 (Reuters) - Britain's departure from the European Union would threaten scientific research and jeopardise the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday.